Jonathan Feddock is an Oncology physician affiliated with Central Baptist Hospital. OpenAlex indexes 50 publications with 480 citations (h-index 14); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Rose Street Hq-101
Lexington, KY 405360293
Telephone
859-229-2726Registry record last updated 9 Jul 2008.
Clinical trials
- Reirradiation With Concurrent Paclitaxel for Breast Cancer
Sponsor: University of Kentucky
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Cumberland Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
65.6%alpha-Adrenergic Blocker65.6%Tamsulosin Hcl100%Part D≥30 patientsMetabolism & gastrointestinal
13.9%Serotonin-3 Receptor Antagonist13.9%Ondansetron Odt100%Part D<11 patientsAnti-infectives
10.7%Penicillins with extended spectrum10.7%Amoxicillin-Clavulanate Potass100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) vs. Conventional Radiotherapy (4FRT) for Locoregionally Advanced Cervical Cancer on the NRG GY006 Trial
International Journal of Radiation Oncology*Biology*Physics
2024 - O006/#1066 Randomized trial of pelvic radiation with and without concurrent cisplatin in patients with a pelvic only recurrence of endometrial cancer
International Journal of Gynecological Cancer
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Firas Badin, MD
Central Baptist Hospital
Hope Cottrill, MD
Central Baptist Hospital
Douglas Milligan, MD
Central Baptist Hospital
Alan Beckman, MD
Central Baptist Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”